As of 2025-10-24, the Intrinsic Value of Atossa Therapeutics Inc (ATOS) is -1.01 USD. This Atossa valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.92 USD, the upside of Atossa Therapeutics Inc is -210.66%.
Based on its market price of 0.92 USD and our intrinsic valuation, Atossa Therapeutics Inc (ATOS) is overvalued by 210.66%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.01 - -1.01 | -1.01 | -210.66% |
| P/E | (0.05) - (0.08) | (0.07) | -107.3% |
| DDM - Stable | (1.51) - (10.26) | (5.88) | -742.5% |
| DDM - Multi | (1.18) - (6.75) | (2.06) | -324.9% |
| Market Cap (mil) | 118.24 |
| Beta | 2.18 |
| Outstanding shares (mil) | 129.17 |
| Enterprise Value (mil) | 118.24 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.13% |
| Cost of Debt | 5.00% |
| WACC | 6.90% |